Skip to content

Questionnaire survey for the unsuitability polypharmacy and medication management in elderly patients with chronic diseases

Questionnaire survey for the unsuitability polypharmacy and medication management in elderly patients with chronic diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020808
Enrollment
Unknown
Registered
2019-01-20
Start date
2019-02-16
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension, diabetes, cerebral apoplexy, cerebral infarction

Interventions

Case series:Nil

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 65 years old; 2. Diagnosis includes hypertension, hyperlipidemia, coronary heart disease, stroke, diabetes, more than one; 3. Use = 5 long-term (= 28 days) use of drugs (systemic drugs); 4. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Can not cooperate, can not sign informed consent; 2. Patients with malignant tumors and other progressive diseases and chronic diseases, patients with an expected survival rate of = 3 months.

Design outcomes

Primary

MeasureTime frame
The incidence of polypharmacy in elderly patients;The variety and incidence of PIM using in elderly patients; Related influencing factors of PIM using in the elderly patients;

Countries

China

Contacts

Public ContactYan Suying

Xuanwu Hospital, Capital Medical University

yansuying10@xwhosp.org+86 010 83108682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026